What question did this study set out to answer?

This study aims to characterize metabolic phenotypes in type 2 diabetes patients and assess their connection to glycemic control.

June 28, 2026BMC Endocrine DisordersOpen Access

Metabolic phenotype stratification identifies patients at high risk of poor glycemic control in type 2 diabetes mellitus: Insights into hepatic metabolic dysfunction

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Type 2 diabetes mellitus (n=320). Intervention: High hepatic metabolic burden phenotype (Cluster 2) vs. Other metabolic phenotypes. Primary outcome: Poorly controlled blood glucose.

View Full Paper

Ask AI

Bookmark

Key result

High hepatic metabolic burden phenotype links to poor glycemic control, with a predictive AUC of ~0.94.

n=320

Population

320 patients with Type 2 diabetes mellitus (T2DM)

Design

Cohort

Authors

WQWenxuan QiChangzhi University WZWenhua ZhaoSouth China Agricultural University LCLi ChenChangzhi University

Discussion

Member takes

Implication

Stratifying T2DM patients by hepatic metabolic burden identifies those at high risk for poor glycemic control, with a predictive model achieving an AUC of 0.943.

Key Points

This study aims to characterize metabolic phenotypes in type 2 diabetes patients and assess their connection to glycemic control.
320 patients with type 2 diabetes mellitus were retrospectively enrolled.
Unsupervised clustering analysis was used to identify metabolic risk profiles.
Multivariate logistic regression evaluated independent risk factors for poor glycemic control.
Cluster 2 patients had significantly higher HbA1c levels and greater poor glycemic control incidence.
HbA1c positively correlated with ALT, AST, fatty liver severity, and HOMA-IR; negatively with HDL-C.
The predictive model achieved an AUC of 0.943, indicating high accuracy.

Study Design

Type

Observational (n=320)

Structured PICO

Population

320 patients with Type 2 diabetes mellitus retrospectively evaluated to assess the association between integrated hepatic metabolic phenotypes and poor glycemic control.

Outcome

Poor glycemic control (assessed via HbA1c levels)surrogate

Stratifying T2DM patients by hepatic metabolic burden identifies those at high risk for poor glycemic control, with a predictive model achieving an AUC of 0.943.

Cite This Study

Qi et al. (2026) conducted an observational in Type 2 diabetes mellitus (n=320). High hepatic metabolic burden phenotype (Cluster 2) vs. Other metabolic phenotypes was evaluated on Poorly controlled blood glucose. A high hepatic metabolic burden phenotype was an independent risk factor for poorly controlled blood glucose, with a combined predictive model achieving an AUC of 0.943.

synapsesocial.com/papers/6a40b9c461bb0a67205c5e84 https://doi.org/10.1186/s12902-026-02365-0

View Full Paper

Ask AI

Bookmark

Implication

Stratifying T2DM patients by hepatic metabolic burden identifies those at high risk for poor glycemic control, with a predictive model achieving an AUC of 0.943.

Metabolic phenotype stratification identifies patients at high risk of poor glycemic control in type 2 diabetes mellitus: Insights into hepatic metabolic dysfunction

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Metabolic phenotype stratification identifies patients at high risk of poor glycemic control in type 2 diabetes mellitus: Insights into hepatic metabolic dysfunction

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Also Consider

Also Consider